In June, the Gillingham & Shaftesbury News reported that Merck Life Science is investing €9 million ($10 million) to add 56,511ft2 (5,250 m2) to its 102,257 ft2 (9,500 m2) distribution facility in Gillingham, UK. The facility is scheduled to open in early 2019.
In July, Shimadzu acquired infraserv Vakuumservice (IVG), which services turbomolecular pumps in Europe. IVG will now work with European customers previously served by Shimadzu’s North American subsidiary. Shimadzu’s turbomolecular pump sales rose 34% last year. Shimadzu aims to increase IVG sales to €21 million ($24 million) by 2022. In 2017, IVG generated revenues of €4.9 million ($5.5 million).
Agilent Technologies announced in July a collaboration with Singapore’s Nanyang Technological University to develop new approaches to testing and monitoring Southeast Asia’s water supply for emerging contaminants.
In July, Agilent Technologies named Robert W. McMahon, CFO of Hologic, to replace senior vice president and current CFO Didier Hirsch, effective September 1.
Working with Health Innovation Manchester, QIAGEN announced in July a partnership with multiple organizations to support the creation of the Genomic Health Innovation Campus in Manchester, UK. QIAGEN currently employs 270 at its operations in Manchester, the location of the company’s European Center of Excellence for Precision Medicine.
In July, GE Healthcare reported second quarter sales for its Life Sciences business increased 5%. Segment orders rose 12%, 9% on an organic basis, as Bioprocess orders grew 14% organically.
Oxford Instruments announced in July the death of Chairman Alan Thomson. Stephen Blair, senior independent director, has taken over as interim chairman.
Mettler-Toledo’s second quarter revenue for its Laboratory segment grew 14% in US dollars and 10% in local currency to $361.7 million, or 51% of total company sales. The acquisition of Biotix (see IBO 11/15/17) added 3% to segment growth. Lab sales in China rose more than 20%. The company also disclosed that the Process Analytics business makes up 10% of segment sales.
In July, Spectris named Andrew Heath as chief executive designate, effective September 3. He will become chief executive no later than September 28. He previously served as CEO of Imagination Technologies.